SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Saliva Diagnostics (SALV)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: RSH who wrote (3246)10/26/1999 10:59:00 AM
From: Bruce Rozenblit   of 3369
 
That was almost 2 years ago. Since then I've learned that the FDA does not support on site, instant Aids testing because the CDC wants to track the carriers. That means the drug companies can't make any money off of the test. This does not work in the real world because about 50% of the people that come into clinics to get tested never come back to get the results. It's a lot of political bullshit. The best market is overseas in Asia and Africa where the disease is rampant but those countries are broke.

By the way, Salv was supposed to have developed and H. Pylori (ulcer bacteria) test that was approved. Where is it?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News